8-K - BriaCell Therapeutics Corp. | StockGist

Current Report Details

Event Type

Material Agreement

Other Event

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement. On January 15, 2026, BriaCell Therapeutics Corp. (the “Company”) consummated a public offering of 4,327,530 units (t

Material Agreement

$5.59$5.59$30.0M$8.39

Source Document

8.01

. Other Events The Company issued press releases announcing the pricing and closing of the Offering on January 13, 2026, and January 15, 2026, respectively. Cop

Other Event

9.01

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 1.1 Placement Agency Agreement, dated as of January 13, 2026, by and between BriaCell Th

Exhibits Only

Source Document

Exhibits (8)

10.1

EX-10.1

1.1

EX-1.1

4.1

EX-4.1

4.2

EX-4.2

4.3

EX-4.3

8-K

99.1

EX-99.1

99.2

EX-99.2